報價延遲最少15分鐘:2025/08/18 16:08 EDT
盤後時段
|
||||
|
7.2498 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
7.41
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-14.95/-3.00
|
|
企業價值
1.08B
|
| 資產負債 |
|
每股賬面淨值
0.04
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/08/18 16:08 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| 180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming. |
